() has achieved the 1,000-patient milestone, a +53% increase on the 651 patients reported on April 29, 2019.
The licensed producer and supplier of pharmaceutical grade medicinal cannabis has added 227 new patients in the month of May and is now averaging more than 11 new patients per business day.
Importantly, the milestone was achieved five months ahead of Althea’s previously stated goal of having its products prescribed to 1,000 patients by November 2019.
In addition to passing the 1,000-patient mark and 227 patients in a single month, there are now 185 Australian Healthcare Professionals (s) who have prescribed Althea’s products.
The company expects to increase the number of Althea prescribers to 200, by month’s end.
Althea CEO and managing director Josh Fegan said: “Reaching the 1,000 patient…